Squamous cell carcinoma transformation from adenocarcinoma as an acquired resistance after the EGFR TKI therapy in (EGFR-mutated) non-small cell lung cancer.

Shinji Shinohara,Yoshinobu Ichiki, Yukiko Fukuichi,Yohei Honda,Masatoshi Kanayama,Akihiro Taira,Yusuke Nabe,Taiji Kuwata,Masaru Takenaka,Soichi Oka,Yasuhiro Chikaishi,Ayako Hirai,Naoko Imanishi,Koji Kuroda,Kazue Yoneda,Hirotsugu Noguchi,Fumihiro Tanaka

JOURNAL OF THORACIC DISEASE（2018）

引用 13|浏览13

暂无评分

摘要

Lung cancer remains the leading cause of cancer mortality worldwide. The incidence of recurrence or distant metastasis after complete resection of primary tumors is reported to be 37%, even in patients with stage I non-small cell lung carcinoma (NSCLC) (1).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要